Sharon Mates
Net Worth

Last updated:

What is Sharon Mates net worth?

The estimated net worth of Dr. Sharon Mates is at least $230,737,375 as of 5 Dec 2024. He owns shares worth $141,144,285 as insider, has earned $73,313,090 from insider trading and has received compensation worth at least $16,280,000 in Intra-Cellular Therapies, Inc..

What is the salary of Sharon Mates?

Dr. Sharon Mates salary is $1,480,000 per year as Co-Founder, Chairman, Chief Executive Officer & Pres in Intra-Cellular Therapies, Inc..

How old is Sharon Mates?

Dr. Sharon Mates is 72 years old, born in 1953.

What stocks does Sharon Mates currently own?

As insider, Dr. Sharon Mates owns shares in one company:

Company Title Shares Price per share Total value
Intra-Cellular Therapies, Inc. (ITCI) Co-Founder, Chairman, Chief Executive Officer & Pres 1,070,329 $131.87 $141,144,285

What does Intra-Cellular Therapies, Inc. do?

Intra-Cellular Therapies, Inc., a biopharmaceutical company, develops novel drugs for the treatment of neuropsychiatric and neurologic diseases by targeting intracellular signaling mechanisms within the central nervous system in the United States. The company offers CAPLYTA for the treatment of schizophrenia in adults. It is also involved in developing lumateperone, which is in Phase III clinical trial for the treatment of bipolar depression, as well as to treat autism spectrum disorder; and in additional neuropsychiatric indications, such as sleep disorders associated with neuropsychiatric and neurological disorders. In addition, the company is developing Lenrispodun (ITI-214) for the treatment of Parkinson's disease and heart failure; ITI-1284-ODT-SL for the treatment of neuropsychiatric disorders and behavioral disturbances in dementia; and ITI-333 for substance use disorders, pain, and psychiatric comorbidities, including depression and anxiety. Intra-Cellular Therapies, Inc. was founded in 2002 and is headquartered in New York, New York.

ITCI logo
ITCI
Intra-Cellular Therapies, Inc.
$131.87

Sharon Mates insider trading

Intra-Cellular Therapies, Inc.

Dr. Sharon Mates has made 84 insider trades between 2014-2024, according to the Form 4 filled with the SEC. Most recently he sold 50,163 units of ITCI stock worth $4,216,953 on 5 Dec 2024.

The largest trade he's ever made was exercising 101,895 units of ITCI stock on 8 Jan 2020. As of 5 Dec 2024 he still owns at least 1,070,329 units of ITCI stock.

Transaction Date Security Shares Price per share Total value Source
Sale
Common Stock 50,163 $84.07 $4,216,953
Option
Common Stock 51,697 $12.73 $658,103
Option
Stock Option (right to buy) 51,697 $12.73 $658,103
Sale
Common Stock 1,534 $84.69 $129,914
Sale
Common Stock 27,667 $85.62 $2,368,904
Option
Stock Option (right to buy) 51,000 $12.73 $649,230
Option
Common Stock 51,000 $12.73 $649,230
Sale
Common Stock 23,333 $86.01 $2,006,755
Option
Common Stock 34,396 $12.73 $437,861
Sale
Common Stock 6,193 $73.32 $454,089
Sale
Common Stock 28,203 $72.73 $2,051,261
Option
Stock Option (right to buy) 34,396 $12.73 $437,861
Option
Stock Option (right to buy) 35,604 $12.73 $453,239
Option
Common Stock 35,604 $12.73 $453,239
Sale
Common Stock 29,832 $72.44 $2,161,120
Sale
Common Stock 5,772 $73.25 $422,770
Option
Common Stock 32,699 $17.57 $574,521
Sale
Common Stock 240 $73.7 $17,688
Sale
Common Stock 32,459 $72.74 $2,361,100
Option
Stock Option (right to buy) 32,699 $17.57 $574,521
Option
Common Stock 40,513 $17.57 $711,813
Option
Stock Option (right to buy) 40,513 $17.57 $711,813
Sale
Common Stock 16,856 $73.93 $1,246,198
Sale
Common Stock 23,657 $73.33 $1,734,862
Option
Common Stock 22,713 $17.57 $399,067
Sale
Common Stock 22,713 $74.59 $1,694,231
Option
Stock Option (right to buy) 22,713 $17.57 $399,067
Sale
Common Stock 28,680 $74.46 $2,135,427
Option
Common Stock 28,680 $17.57 $503,908
Option
Stock Option (right to buy) 28,680 $17.57 $503,908
Option
Stock Option (right to buy) 39,380 $17.57 $691,907
Sale
Common Stock 35,011 $74.58 $2,611,085
Sale
Common Stock 4,369 $75.47 $329,728
Option
Common Stock 39,380 $17.57 $691,907
Sale
Common Stock 1,900 $77.98 $148,164
Sale
Common Stock 2,682 $77.21 $207,088
Option
Stock Option (right to buy) 53,013 $17.57 $931,438
Sale
Common Stock 4,297 $76.2 $327,431
Sale
Common Stock 44,134 $75.4 $3,327,836
Option
Common Stock 53,013 $17.57 $931,438
Option
Stock Option (right to buy) 8,638 $16.86 $145,637
Option
Common Stock 11,382 $17.57 $199,982
Option
Common Stock 8,638 $16.86 $145,637
Option
Stock Option (right to buy) 11,382 $17.57 $199,982
Sale
Common Stock 306 $67.33 $20,603
Sale
Common Stock 14,541 $64.8 $942,257
Sale
Common Stock 4,128 $65.9 $272,035
Sale
Common Stock 1,590 $66.81 $106,228
Option
Common Stock 20,565 N/A N/A
Option
Restricted Stock Units 20,565 N/A N/A
Sale
Common Stock 8,754 $66.93 $585,905
Sale
Common Stock 31,958 $66.38 $2,121,372
Option
Restricted Stock Units 40,712 N/A N/A
Option
Common Stock 40,712 N/A N/A
Sale
Common Stock 12,462 $70.11 $873,711
Sale
Common Stock 600 $68.39 $41,034
Sale
Common Stock 9,528 $69.45 $661,720
Option
Common Stock 22,590 N/A N/A
Option
Restricted Stock Units 22,590 N/A N/A
Sale
Common Stock 16,435 $66.7 $1,096,215
Sale
Common Stock 17,450 $67.42 $1,176,479
Sale
Common Stock 67,597 $65.19 $4,406,648
Option
Stock Option (right to buy) 67,917 $16.86 $1,145,081
Sale
Common Stock 320 $66.25 $21,200
Option
Common Stock 67,917 $16.86 $1,145,081
Sale
Common Stock 17,451 $66.66 $1,163,284
Option
Stock Option (right to buy) 48,084 $16.86 $810,696
Sale
Common Stock 30,633 $66 $2,021,778
Option
Common Stock 48,084 $16.86 $810,696
Sale
Common Stock 3,500 $66.38 $232,330
Option
Stock Option (right to buy) 75,361 $16.86 $1,270,586
Option
Common Stock 75,361 $16.86 $1,270,586
Sale
Common Stock 5,882 $67.76 $398,564
Sale
Common Stock 65,979 $67.25 $4,437,088
Sale
Common Stock 44,413 $54.17 $2,405,852
Sale
Common Stock 27,468 $53.55 $1,470,911
Sale
Common Stock 28,119 $53.96 $1,517,301
Option
Stock Option (right to buy) 20,000 $3.26 $65,200
Sale
Common Stock 1,412 $44.08 $62,241
Option
Common Stock 20,000 $3.26 $65,200
Sale
Common Stock 19,153 $45.06 $863,034
Sale
Common Stock 6,805 $42.51 $289,281
Option
Restricted Stock Units 20,565 N/A N/A
Option
Common Stock 20,565 N/A N/A
Sale
Common Stock 34,965 $43.28 $1,513,285
Option
Stock Option (right to buy) 30,000 $3.26 $97,800
Option
Common Stock 30,000 $3.26 $97,800
Sale
Common Stock 22,590 $47.03 $1,062,408
Option
Common Stock 22,590 N/A N/A
Option
Restricted Stock Units 22,590 N/A N/A
Sale
Common Stock 22,895 $46.54 $1,065,533
Sale
Common Stock 2,502 $48.7 $121,847
Sale
Common Stock 251 $49.6 $12,450
Sale
Common Stock 2,200 $47.35 $104,170
Option
Restricted Stock Units 27,848 N/A N/A
Option
Common Stock 27,848 N/A N/A
Sale
Common Stock 33,083 $55 $1,819,565
Option
Common Stock 38,925 $2.84 $110,547
Option
Stock Option (right to buy) 38,925 $2.84 $110,547
Sale
Common Stock 100 $50.92 $5,092
Sale
Common Stock 11,249 $52.35 $588,885
Option
Restricted Stock Units 22,589 N/A N/A
Sale
Common Stock 11,240 $51.61 $580,096
Option
Common Stock 22,589 N/A N/A
Sale
Common Stock 15,180 $55.73 $845,981
Sale
Common Stock 12,667 $54.98 $696,432
Option
Restricted Stock Units 27,847 N/A N/A
Option
Common Stock 27,847 N/A N/A
Sale
Common Stock 27,138 $40.8 $1,107,230
Sale
Common Stock 8,954 $40.1 $359,055
Option
Restricted Stock Units 41,896 N/A N/A
Sale
Common Stock 5,804 $41.72 $242,143
Option
Common Stock 41,896 N/A N/A
Sale
Common Stock 8,192 $40 $327,680
Option
Stock Option (right to buy) 1,075 $2.84 $3,053
Sale
Common Stock 40,392 $40 $1,615,680
Option
Common Stock 1,075 $2.84 $3,053
Sale
Common Stock 1,416 $40 $56,640
Option
Common Stock 10,000 $2.84 $28,400
Option
Stock Option (right to buy) 10,000 $2.84 $28,400
Sale
Common Stock 27,847 $19.46 $541,763
Sale
Common Stock 27,847 N/A N/A
Option
Restricted Stock Units 27,847 N/A N/A
Option
Common Stock 27,847 N/A N/A
Sale
Common Stock 41,896 N/A N/A
Sale
Common Stock 41,896 $16.03 $671,593
Option
Common Stock 41,896 N/A N/A
Option
Restricted Stock Units 41,896 N/A N/A
Sale
Common Stock 48,341 $31.17 $1,506,547
Sale
Common Stock 48,341 N/A N/A
Sale
Common Stock 48,341 $15.58 $753,298
Option
Restricted Stock Units 34,341 N/A N/A
Option
Common Stock 34,341 N/A N/A
Option
Stock Option (right to buy) 34,000 N/A N/A
Option
Common Stock 34,000 N/A N/A
Sale
Common Stock 50,000 N/A N/A
Sale
Common Stock 50,000 N/A N/A
Sale
Common Stock 41,895 N/A N/A
Option
Common Stock 101,895 $2.74 $279,192
Option
Restricted Stock Units 41,895 N/A N/A
Option
Stock Option (right to buy) 60,000 N/A N/A
Option
Common Stock 101,895 N/A N/A
Sale
Common Stock 45,598 N/A N/A
Option
Common Stock 45,598 N/A N/A
Option
Restricted Stock Units 45,598 N/A N/A
Sale
Common Stock 17,478 $32.96 $576,040
Sale
Common Stock 17,478 N/A N/A
Option
Stock Option (right to buy) 6,000 N/A N/A
Option
Common Stock 6,000 N/A N/A
Sale
Common Stock 6,604 N/A N/A
Option
Restricted Stock Units 6,604 N/A N/A
Option
Common Stock 6,604 N/A N/A
Sale
Common Stock 45,598 N/A N/A
Option
Restricted Stock Units 45,598 N/A N/A
Option
Common Stock 45,598 N/A N/A
Option
Common Stock 45,598 N/A N/A
Option
Restricted Stock Units 45,598 N/A N/A
Sale
Common Stock 17,478 N/A N/A
Option
Stock Option (right to buy) 50,000 N/A N/A
Option
Common Stock 50,000 N/A N/A
Sale
Common Stock 6,604 N/A N/A
Sale
Common Stock 11,257 N/A N/A
Option
Restricted Stock Units 6,604 N/A N/A
Option
Common Stock 6,604 N/A N/A
Option
Restricted Stock Units 11,257 N/A N/A
Option
Common Stock 11,257 N/A N/A
Sale
Common Stock 18,750 N/A N/A
Option
Common Stock 18,750 N/A N/A
Option
Stock Option (right to buy) 18,750 N/A N/A
Sale
Common Stock 4,081 N/A N/A
Option
Common Stock 6,603 N/A N/A
Option
Restricted Stock Unit 6,603 N/A N/A
Option
Common Stock 68,750 N/A N/A
Option
Stock Option (right to buy) 43,750 $1.05 $45,938
Option
Stock Option (right to buy) 43,750 N/A N/A
Option
Common Stock 68,750 $0.9 $61,875
Sale
Common Stock 51,500 N/A N/A
Sale
Common Stock 35,000 N/A N/A
Option
Common Stock 50,000 N/A N/A
Option
Stock Option (right to buy) 50,000 N/A N/A

Intra-Cellular Therapies key executives

Intra-Cellular Therapies, Inc. executives and other stock owners filed with the SEC: